These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 29480508)
1. Understanding the roles of negative immune regulator TIPE2 in different diseases and tumourigenesis. Li Z; Jia W; Niu J; Zhang L Histol Histopathol; 2018 Sep; 33(9):919-928. PubMed ID: 29480508 [TBL] [Abstract][Full Text] [Related]
2. TIPE2: A Candidate for Targeting Antitumor Immunotherapy. Xu L; Pan F; Guo Z J Immunol; 2024 Mar; 212(5):755-763. PubMed ID: 38377476 [TBL] [Abstract][Full Text] [Related]
3. Research progress of TIPE2 in immune-related diseases. Gao J; Zhang H; Zhang F Int Immunopharmacol; 2023 Aug; 121():110514. PubMed ID: 37348234 [TBL] [Abstract][Full Text] [Related]
4. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Sun H; Gong S; Carmody RJ; Hilliard A; Li L; Sun J; Kong L; Xu L; Hilliard B; Hu S; Shen H; Yang X; Chen YH Cell; 2008 May; 133(3):415-26. PubMed ID: 18455983 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory TIPE2 inhibits angiogenic VEGF in retinal pigment epithelium. Suo LG; Cui YY; Bai Y; Qin XJ Mol Immunol; 2016 May; 73():46-52. PubMed ID: 27043859 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of Tumor Necrosis Factor- Liu Y; Wang X; Zhao Y; Zhao P; Wang L; Zhai Q; Zhang X; Tian W; Xiang X; Li T J Diabetes Res; 2017; 2017():4802319. PubMed ID: 28626770 [TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor-α-induced protein 8-like 2 is a novel regulator of proliferation, migration, and invasion in human rectal adenocarcinoma cells. Wu DD; Liu SY; Gao YR; Lu D; Hong Y; Chen YG; Dong PZ; Wang DY; Li T; Li HM; Ren ZG; Guo JC; He F; Ren XQ; Sun SY; Duan SF; Ji XY J Cell Mol Med; 2019 Mar; 23(3):1698-1713. PubMed ID: 30637920 [TBL] [Abstract][Full Text] [Related]
8. Loss of TIPE2 Has Opposing Effects on the Pathogenesis of Autoimmune Diseases. Liu R; He X; Geng W; Wang T; Ruan Q Front Immunol; 2019; 10():2284. PubMed ID: 31616442 [TBL] [Abstract][Full Text] [Related]
9. The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Zhang L; Shi Y; Wang Y; Zhu F; Wang Q; Ma C; Chen YH; Zhang L Mol Immunol; 2011 May; 48(9-10):1209-15. PubMed ID: 21459448 [TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of TIPE2 provides insights into its function. Zhang G; Hao C; Lou Y; Xi W; Wang X; Wang Y; Qu Z; Guo C; Chen Y; Zhang Y; Liu S Mol Immunol; 2010 Sep; 47(15):2435-42. PubMed ID: 20663561 [TBL] [Abstract][Full Text] [Related]
11. TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal. Oho M; Nakano R; Nakayama R; Sakurai W; Miyamoto A; Masuhiro Y; Hanazawa S J Biol Chem; 2016 Oct; 291(43):22650-22660. PubMed ID: 27601471 [TBL] [Abstract][Full Text] [Related]
12. TIPE2 in dendritic cells inhibits the induction of pTregs in the gut mucosa. Liu R; Liu C; Liu C; Fan T; Geng W; Ruan Q Biochem Biophys Res Commun; 2019 Feb; 509(4):911-917. PubMed ID: 30638932 [TBL] [Abstract][Full Text] [Related]
13. TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway. Sun H; Zhuang G; Chai L; Wang Z; Johnson D; Ma Y; Chen YH J Immunol; 2012 Sep; 189(6):2768-73. PubMed ID: 22904303 [TBL] [Abstract][Full Text] [Related]
14. TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression. Li Z; Guo C; Liu X; Zhou C; Zhu F; Wang X; Wang Q; Shi Y; Wang J; Zhao W; Zhang L Oncotarget; 2016 Sep; 7(38):62224-62239. PubMed ID: 27556698 [TBL] [Abstract][Full Text] [Related]
15. TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling. Peng Y; Zhao Q; Zhang H; Han B; Liu S; Han M; Liu S Oncol Rep; 2016 Apr; 35(4):2480-6. PubMed ID: 26781452 [TBL] [Abstract][Full Text] [Related]
16. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice. Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221 [TBL] [Abstract][Full Text] [Related]
17. TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer. Wu J; Zhang H; Xu C; Xu H; Zhou X; Xie Y; Tao M Int J Oncol; 2016 Jan; 48(1):199-206. PubMed ID: 26530498 [TBL] [Abstract][Full Text] [Related]
18. TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation. Zhang YH; Yan HQ; Wang F; Wang YY; Jiang YN; Wang YN; Gao FG Int J Oncol; 2015 Jan; 46(1):254-64. PubMed ID: 25339267 [TBL] [Abstract][Full Text] [Related]
19. Regulatory Roles of Tumor Necrosis Factor-α-Induced Protein 8 Like-Protein 2 in Inflammation, Immunity and Cancers: A Review. Gu Z; Cui X; Sun P; Wang X Cancer Manag Res; 2020; 12():12735-12746. PubMed ID: 33364825 [TBL] [Abstract][Full Text] [Related]
20. TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury. Zhang H; Zhu T; Liu W; Qu X; Chen Y; Ren P; Wang Z; Wei X; Zhang Y; Yi F J Mol Med (Berl); 2015 Sep; 93(9):1033-43. PubMed ID: 25877863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]